High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
Abstract A deeper understanding of COVID‐19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)‐based proteomics to measure serum proteomes of COVID‐19 patients and symptomatic, but...
Saved in:
| Main Authors: | Philipp E Geyer, Florian M Arend, Sophia Doll, Marie‐Luise Louiset, Sebastian Virreira Winter, Johannes B Müller‐Reif, Furkan M Torun, Michael Weigand, Peter Eichhorn, Mathias Bruegel, Maximilian T Strauss, Lesca M Holdt, Matthias Mann, Daniel Teupser |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-07-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202114167 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Revisiting biomarker discovery by plasma proteomics
by: Philipp E Geyer, et al.
Published: (2017-09-01) -
Assessment of the reliability of serological monitoring results based on biobank materials
by: A. V. Nozdracheva, et al.
Published: (2023-12-01) -
Influence of long-term storage of blood serum samples in a biobank for population-based seroepidemiologic studies
by: A. V. Nozdracheva, et al.
Published: (2022-12-01) -
From idea to implementation: the development of biobanking in Russia. The Cardiovascular Therapy and Prevention journal’s top contributing institutions: National Association of Biobanks and Biobanking Specialists (NASBIO)
by: A. N. Meshkov, et al.
Published: (2023-12-01) -
Training in biobanking in the context of modern medical education
by: T. S. Sokolova, et al.
Published: (2022-12-01)